Theresa Greco - Nov 1, 2023 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Commercial Officer
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Stock symbol
OPRX
Transactions as of
Nov 1, 2023
Transactions value $
$0
Form type
4
Date filed
11/3/2023, 10:49 AM
Previous filing
Oct 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Award $0 +18.5K +100% $0.00 37K Nov 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Stock Option Award $0 +35.8K $0.00 35.8K Nov 1, 2023 Common Stock 35.8K $8.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on November 1, 2024, which is the first anniversary of the date of grant.
F2 The stock option vests in three equal annual installments beginning November 1, 2024, the first anniversary of the grant date.